# FMC Corp: overview

FMC · NYSE · CIK 37785 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fmc.md) · [Financials](/companies/fmc/financials.md) · [Filings](/companies/fmc/filings.md) · [Insiders](/companies/fmc/insiders.md)

Latest reported revenue: [$867.1m](/filings/0000037785-26-000142.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 30, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000037785-26-000142).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,065](/filings/0000037785-26-000041.md) | [1,224](/filings/0000037785-26-000041.md) | [791](/filings/0000037785-26-000096.md) | [1,051](/filings/0000037785-26-000142.md) | [542](/filings/0000037785-26-000041.md) | [1,083](/filings/0000037785-26-000041.md) | [759](/filings/0000037785-26-000096.md) | [867](/filings/0000037785-26-000142.md) |
| Gross margin | % | [36.3%](/filings/0000037785-26-000041.md) | [42.9%](/filings/0000037785-26-000041.md) | [40.0%](/filings/0000037785-26-000096.md) | [38.7%](/filings/0000037785-26-000142.md) | [23.8%](/filings/0000037785-26-000041.md) | [39.8%](/filings/0000037785-26-000041.md) | [32.5%](/filings/0000037785-26-000096.md) | [39.5%](/filings/0000037785-26-000142.md) |
| Operating margin | % | [12.7%](/filings/0000037785-26-000041.md) | [19.2%](/filings/0000037785-26-000041.md) | [7.4%](/filings/0000037785-26-000096.md) | [12.0%](/filings/0000037785-26-000142.md) | [(73.1%)](/filings/0000037785-26-000041.md) | [(130.8%)](/filings/0000037785-26-000041.md) | [(10.7%)](/filings/0000037785-26-000096.md) | [(13.8%)](/filings/0000037785-26-000142.md) |
| Net margin | % | [6.1%](/filings/0000037785-26-000041.md) | [(1.3%)](/filings/0000037785-26-000041.md) | [(2.0%)](/filings/0000037785-26-000096.md) | [6.3%](/filings/0000037785-26-000142.md) | [(105.0%)](/filings/0000037785-26-000041.md) | [(158.8%)](/filings/0000037785-26-000041.md) | [(37.1%)](/filings/0000037785-26-000096.md) | [(21.5%)](/filings/0000037785-26-000142.md) |
| Diluted EPS | $ per share | [0.52](/filings/0000037785-26-000041.md) | [(0.13)](/filings/0000037785-26-000041.md) | [(0.12)](/filings/0000037785-26-000096.md) | [0.53](/filings/0000037785-26-000142.md) | [(4.52)](/filings/0000037785-26-000041.md) | [(13.74)](/filings/0000037785-26-000041.md) | [(2.25)](/filings/0000037785-26-000096.md) | [(1.49)](/filings/0000037785-26-000142.md) |
| Free cash flow | $m | [144 d](/filings/0000037785-25-000127.md) | [406 d](/filings/0000037785-26-000041.md) | [(577)](/filings/0000037785-26-000096.md) | [50.9 d](/filings/0000037785-26-000142.md) | [(208) d](/filings/0000037785-25-000127.md) | [631 d](/filings/0000037785-26-000041.md) | [(618)](/filings/0000037785-26-000096.md) | [358 d](/filings/0000037785-26-000142.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,045](/filings/0000037785-24-000033.md) | [5,802](/filings/0000037785-25-000030.md) | [4,487](/filings/0000037785-26-000041.md) | [4,246](/filings/0000037785-26-000041.md) | [3,467](/filings/0000037785-26-000041.md) |
| Gross margin | % | [42.8%](/filings/0000037785-24-000033.md) | [40.1%](/filings/0000037785-25-000030.md) | [40.8%](/filings/0000037785-26-000041.md) | [38.8%](/filings/0000037785-26-000041.md) | [37.0%](/filings/0000037785-26-000041.md) |
| Operating margin | % | [20.5%](/filings/0000037785-24-000033.md) | [19.7%](/filings/0000037785-25-000030.md) | [12.4%](/filings/0000037785-26-000041.md) | [11.9%](/filings/0000037785-26-000041.md) | [(47.0%)](/filings/0000037785-26-000041.md) |
| Net margin | % | [14.7%](/filings/0000037785-24-000033.md) | [12.7%](/filings/0000037785-25-000030.md) | [29.5%](/filings/0000037785-26-000041.md) | [8.0%](/filings/0000037785-26-000041.md) | [(64.6%)](/filings/0000037785-26-000041.md) |
| Diluted EPS | $ per share | [5.73](/filings/0000037785-24-000033.md) | [5.81](/filings/0000037785-25-000030.md) | [10.53](/filings/0000037785-26-000041.md) | [2.72](/filings/0000037785-26-000041.md) | [(17.88)](/filings/0000037785-26-000041.md) |
| Free cash flow | $m | [799](/filings/0000037785-24-000033.md) | [518](/filings/0000037785-25-000030.md) | [(434)](/filings/0000037785-26-000041.md) | [669](/filings/0000037785-26-000041.md) | [(103)](/filings/0000037785-26-000041.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fmc/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $247.7m | 21,535,604 |  | Added +2,839,000 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $91.1m | 8,021,709 |  | Reduced −1,240,074 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $88.8m | 7,719,466 |  | Added +22,808 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $75.4m | 6,508,595 |  | Added +1,708,564 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $66.2m | 5,758,841 |  | Reduced −7,523 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $58.1m | 5,053,535 |  | Added +2,939,698 |
| [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $56.5m | 4,909,310 |  | Reduced −1,106,717 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $37.7m | 3,277,365 |  | Added +1,176,019 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $32.5m | 2,829,728 |  | Added +447,912 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $29.0m | 2,522,414 |  | Added +1,223,695 |

## Recent filings

[All 1,987 filings](/companies/fmc/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:56 ET | [8-K](/filings/0000037785-26-000168.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000037785-26-000168 |
| 2026-10-21 | 17:04 ET | [8-K](/filings/0000950103-26-015974.md) | 5.02 Departure or appointment of officers or directors | 0000950103-26-015974 |
| 2026-10-21 | 16:30 ET | [8-K](/filings/0001193125-26-427896.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-427896 |
| 2026-10-15 | 08:03 ET | [8-K](/filings/0000037785-26-000149.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000037785-26-000149 |
| 2026-09-25 | 16:15 ET | [SCHEDULE 13D](/filings/0001140361-26-037699.md) | Ownership report, active investor | 0001140361-26-037699 |
| 2026-09-23 | 16:27 ET | [8-K](/filings/0000950103-26-014390.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950103-26-014390 |
| 2026-07-30 | 14:02 ET | [10-Q](/filings/0000037785-26-000142.md) | Quarterly report, period 2026-06-30 | 0000037785-26-000142 |
| 2026-07-29 | 16:44 ET | [8-K](/filings/0000037785-26-000139.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000037785-26-000139 |
| 2026-07-01 | 07:07 ET | [8-K](/filings/0000950103-26-009902.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950103-26-009902 |
| 2026-06-23 | 16:01 ET | [8-K](/filings/0001193125-26-279416.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-279416 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000037785-26-000041.md), filed Feb 27, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 37785
- Tickers: FMC
- Exchange: NYSE
- SIC code: 2800 Chemicals & Allied Products
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 13:53 ET. No prices; not investment advice.